CNO Stock Analysis: Buy, Sell, or Hold?
CNO - CNO Financial Group, Inc.
$55.28
0.43 (0.78%)
▲
5d:
+0.22%
30d:
+3.31%
90d:
+17.14%
HOLD
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When CNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNO trades at premium valuation expecting 4.8% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CNO trades at premium valuation expecting 4.8% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.45
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$39.40
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNO is currently trading at $55.28, which is considered extended relative to its 30-day fair value range of $52.62 to $54.96. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.0) compared to its historical average (9.5). At these levels, the market is pricing in 4.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is currently testing key support at $54.26. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CNO scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is currently testing key support at $54.26. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CNO scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$52.62 -
$54.96
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.9%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.75)
- NEUTRAL: Trading at premium valuation - market expects 4.8% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$52.62 -
$54.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$54.26
Resistance Level
$56.59
Current Trend
Strong Uptrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.99
Wall Street Target
$53.75
(-2.8%)
Revenue Growth (YoY)
11.6%
Earnings Growth (YoY)
46.2%
Profit Margin
6.0%
Valuation Premium vs History
+4.8% premium
PE vs Historical
11.0 vs 9.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.8%
(market-implied from PE analysis)
1-Year Target
$57.93
(+5%)
2-Year Target
$60.71
(+10%)
3-Year Target
$63.63
(+15%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$54.98
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 7.7%)
$126.95
(+130%)
Base:
(SPY PE: 11.0, Growth: 7.7%)
$68.99
(+25%)
Bear:
(PE: 9.3, Growth: 7.7%)
$58.64
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 18.91 | Current EPS (TTM): $2.90
Bull Case
$104.61
(+89%)
Analyst growth 73.4%, PE expands to 20.8
Base Case
$95.10
(+72%)
Market implied 73.4%, PE stable at 18.9
Bear Case
$37.30
(-33%)
Severe decline -20.0%, PE contracts to 16.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 16, 2026 2:21 AM ET
Data refreshes hourly during market hours. Next update: 3:21 AM
Data refreshes hourly during market hours. Next update: 3:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott L Goldberg
SELL
11060 shares
2026-03-19
Gary C Bhojwani
SELL
43021 shares
2026-02-18
Matthew J Zimpfer
SELL
33800 shares
2026-02-18
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$100 | 47 HOLD |
|
UNM
Unum Group |
BUY
13 analysts |
$102 | 51 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 61 BUY |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$36 | 39 SELL |
